These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29449807)

  • 1. Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in
    Colini Baldeschi A; Pittaluga E; Andreola F; Rossi S; Cozzolino M; Nicotera G; Sferrazza G; Pierimarchi P; Serafino A
    Front Aging Neurosci; 2018; 10():20. PubMed ID: 29449807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling.
    Giovannini D; Andreola F; Spitalieri P; Krasnowska EK; Colini Baldeschi A; Rossi S; Sangiuolo F; Cozzolino M; Serafino A
    Cell Death Discov; 2021 Nov; 7(1):330. PubMed ID: 34725335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signaling.
    Serafino A; Moroni N; Psaila R; Zonfrillo M; Andreola F; Wannenes F; Mercuri L; Rasi G; Pierimarchi P
    Biochim Biophys Acta; 2012 Jun; 1822(6):1004-18. PubMed ID: 22387884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.
    Zhou T; Zu G; Zhang X; Wang X; Li S; Gong X; Liang Z; Zhao J
    Neuropharmacology; 2016 Feb; 101():480-9. PubMed ID: 26525190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection.
    L'episcopo F; Serapide MF; Tirolo C; Testa N; Caniglia S; Morale MC; Pluchino S; Marchetti B
    Mol Neurodegener; 2011 Jul; 6():49. PubMed ID: 21752258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.
    L'Episcopo F; Tirolo C; Serapide MF; Caniglia S; Testa N; Leggio L; Vivarelli S; Iraci N; Pluchino S; Marchetti B
    Front Aging Neurosci; 2018; 10():12. PubMed ID: 29483868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease.
    Marchetti B
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease.
    Singh S; Mishra A; Mohanbhai SJ; Tiwari V; Chaturvedi RK; Khurana S; Shukla S
    Free Radic Biol Med; 2018 Dec; 129():73-87. PubMed ID: 30176346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
    Singh S; Mishra A; Shukla S
    Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D1 receptor activation improves adult hippocampal neurogenesis and exerts anxiolytic and antidepressant-like effect via activation of Wnt/β-catenin pathways in rat model of Parkinson's disease.
    Mishra A; Singh S; Tiwari V; Parul ; Shukla S
    Neurochem Int; 2019 Jan; 122():170-186. PubMed ID: 30500462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/β-CATENIN pathway.
    Yang JM; Huang HM; Cheng JJ; Huang CL; Lee YC; Chiou CT; Huang HT; Huang NK; Yang YC
    Toxicology; 2018 Dec; 410():65-72. PubMed ID: 30205152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide: a magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulators.
    Serafino A; Pierimarchi P
    Curr Med Chem; 2014; 21(21):2401-9. PubMed ID: 24524761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.
    Zhang L; Cen L; Qu S; Wei L; Mo M; Feng J; Sun C; Xiao Y; Luo Q; Li S; Yang X; Xu P
    PLoS One; 2016; 11(4):e0152931. PubMed ID: 27045591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of canonical Wnt signaling components has a neuroprotective effect on midbrain dopaminergic neurons in an MPTP-induced mouse model of Parkinson's disease.
    Dai TL; Zhang C; Peng F; Niu XY; Hu L; Zhang Q; Huang Y; Chen L; Zhang L; Zhu W; Ding YQ; Song NN; Liao M
    Exp Ther Med; 2014 Aug; 8(2):384-390. PubMed ID: 25009587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway.
    Salašová A; Yokota C; Potěšil D; Zdráhal Z; Bryja V; Arenas E
    Mol Neurodegener; 2017 Jul; 12(1):54. PubMed ID: 28697798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Morale MC; Serapide MF; Pluchino S; Marchetti B
    J Mol Cell Biol; 2014 Feb; 6(1):13-26. PubMed ID: 24431301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HucMSC extracellular vesicles increasing SATB 1 to activate the Wnt/β-catenin pathway in 6-OHDA-induced Parkinson's disease model.
    He Y; Li R; Yu Y; Xu Z; Gao J; Wang C; Huang C; Qi Z
    IUBMB Life; 2024 Jul; ():. PubMed ID: 39082886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ucf-101 protects in vivoandin vitro models of PD against 6-hydroxydopamine toxicity by alleviating endoplasmic reticulum stress via the Wnt/β-catenin pathway.
    Li Y; Liu Z; Wang D; Gao H; Zhu Z; Wang Y; Luo Q; Jiang S; Zhang J; Yang X
    J Clin Neurosci; 2020 Jan; 71():217-225. PubMed ID: 31883812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Theanine alleviates MPTP-induced Parkinson's disease by targeting Wnt/β-catenin signaling mediated by the MAPK signaling pathway.
    Ratih K; Lee YR; Chung KH; Song DH; Lee KJ; Kim DH; An JH
    Int J Biol Macromol; 2023 Jan; 226():90-101. PubMed ID: 36502788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.